148 related articles for article (PubMed ID: 19799882)
1. The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.
Hammarberg A; Nylander I; Zhou Q; Jayaram-Lindström N; Reid MS; Franck J
Brain Res; 2009 Dec; 1305 Suppl():S2-6. PubMed ID: 19799882
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
Kiefer F; Jahn H; Otte C; Naber D; Wiedemann K
Biol Psychiatry; 2006 Jul; 60(1):74-6. PubMed ID: 16483549
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender.
Gianoulakis C; Dai X; Brown T
Alcohol Clin Exp Res; 2003 Mar; 27(3):410-23. PubMed ID: 12658106
[TBL] [Abstract][Full Text] [Related]
4. Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.
Kiefer F; Jahn H; Otte C; Nakovics H; Wiedemann K
Neurosci Lett; 2006 Aug; 404(1-2):103-6. PubMed ID: 16782270
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.
Zalewska-Kaszubska J; Górska D; Dyr W; Czarnecka E
Neurosci Lett; 2008 Feb; 431(3):221-5. PubMed ID: 18162308
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: a longitudinal study.
Leggio L; Ferrulli A; Cardone S; Malandrino N; Mirijello A; D'Angelo C; Vonghia L; Miceli A; Capristo E; Kenna GA; Gasbarrini G; Swift RM; Addolorato G
Alcohol Clin Exp Res; 2008 Dec; 32(12):2047-53. PubMed ID: 18828809
[TBL] [Abstract][Full Text] [Related]
8. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
Dahl H; Hammarberg A; Franck J; Helander A
Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
[TBL] [Abstract][Full Text] [Related]
9. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.
Ooteman W; Koeter MW; Verheul R; Schippers GM; van den Brink W
Eur Neuropsychopharmacol; 2007 Jul; 17(8):558-66. PubMed ID: 17379484
[TBL] [Abstract][Full Text] [Related]
10. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate.
Zimmerman U; Spring K; Koller G; Holsboer F; Soyka M
Pharmacopsychiatry; 2004 May; 37(3):98-102. PubMed ID: 15179967
[TBL] [Abstract][Full Text] [Related]
13. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes.
Sinha R; Garcia M; Paliwal P; Kreek MJ; Rounsaville BJ
Arch Gen Psychiatry; 2006 Mar; 63(3):324-31. PubMed ID: 16520439
[TBL] [Abstract][Full Text] [Related]
14. Acamprosate: recent findings and future research directions.
Mann K; Kiefer F; Spanagel R; Littleton J
Alcohol Clin Exp Res; 2008 Jul; 32(7):1105-10. PubMed ID: 18540918
[TBL] [Abstract][Full Text] [Related]
15. The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.
Hammarberg A; Jayaram-Lindström N; Beck O; Franck J; Reid MS
Psychopharmacology (Berl); 2009 Jul; 205(1):53-62. PubMed ID: 19319508
[TBL] [Abstract][Full Text] [Related]
16. Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.
Zalewska-Kaszubska J; Cwiek W; Dyr W; Czarnecka E
Neurosci Lett; 2005 Nov; 388(1):45-8. PubMed ID: 16009491
[TBL] [Abstract][Full Text] [Related]
17. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.
Boeijinga PH; Parot P; Soufflet L; Landron F; Danel T; Gendre I; Muzet M; Demazières A; Luthringer R
Neuropsychobiology; 2004; 50(1):71-7. PubMed ID: 15179024
[TBL] [Abstract][Full Text] [Related]
19. Response of the HPA-axis to alcohol and stress as a function of alcohol dependence and family history of alcoholism.
Dai X; Thavundayil J; Santella S; Gianoulakis C
Psychoneuroendocrinology; 2007 Apr; 32(3):293-305. PubMed ID: 17349749
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
